LOS ANGELES, Nov. 10, 2011 /PRNewswire/ -- De Novo Software™, a leading provider of flow cytometry data analysis solutions, and Partec™, a leading provider of flow cytometry instruments and reagents, announced today an agreement whereby Partec will sell De Novo Software's flagship product – FCS Express™ – to customers in clinical, research and pharmaceutical markets worldwide.
Partec will distribute FCS Express with every CyFlow® Cube instrument and resell FCS Express products to customers worldwide. Roland Gohde, Partec's CEO said: "FCS Express is the perfect complement to the CyView™ data acquisition and data display software. As the best-in-class flow cytometry analysis software, FCS Express provides our customers with advanced analysis and reporting capabilities to allow them fully exploiting the power of the CyFlow® Cube."
David Novo, President of De Novo Software, commented: "We are thrilled to be working with Partec. They have been innovators in the field of flow cytometry for the last five decades and we look forward to a close collaboration. It is already possible to launch FCS Express directly from the CyView™ software, and we will work closely to develop innovative workflow and analysis solutions for Partec customers."
Used today by many leading clinical and research laboratories, FCS Express provides comprehensive analysis capabilities, including advanced and easy-to-use report creation tools, 21 CFR Part 11 data security support, quality control alerts, real time bar and scatter plots with updating regression analysis and much more.
The CyFlow® Cube is Partec's newest flow cytometry system and an ideal state-of-the-art tool for a broad range of research applications. As a compact stand-alone desktop instrument, the CyFlow® Cube features a unique and innovative design. The CUBE 8 can optionally be equipped with a cell and particle sorting module.
Customers will be able to purchase FCS Express through the Partec sales force, website, catalog and worldwide network of distributors.
About De Novo Software
De Novo Software is a leading provider of flow and image cytometry analysis. Its primary product, FCS Express, is used by over three thousand laboratories worldwide for research purposes, and dozens of clinical laboratories for high throughput clinical analysis. As the only third-party flow analysis software registered with the FDA for in-vitro diagnostic use, and with full 21 CFR Part 11 compliance features, FCS Express is the analysis tool of choice for the clinical laboratory. In addition, De Novo Software has extensive experience creating custom data analysis solutions and integrating with large scale LIS and HIS systems. For more information, please visit www.denovosoftware.com.
Partec, established in 1967 and headquartered in Germany, is a worldwide leading pioneer, developer and manufacturer of fluorescence-based flow cytometry systems. Partec flow cytometry has become a standard method e.g. for automated rapid analysis and sorting of cells, nanoparticles and microorganisms and precise, accurate cell and particle counting in a wide range of applications in healthcare (e.g. immunology, leukemia, lymphoma, HIV/AIDS), cell biology, microbiology, biotechnology, agrosciences, plant breeding, aquaculture and for quality control in pharmaceutical industry as well as in food and beverage industries. With own subsidiaries and specially trained distributors, Partec is active in more than 100 countries, worldwide. For more information, please visit www.partec.com.
|SOURCE De Novo Software|
Copyright©2010 PR Newswire.
All rights reserved